In this study, we evaluated the ability of EECP, which is endowed with antiestrogenic and anti-mammary tumor properties in rats [16, 20], to counteract tamoxifen-induced endometrial hyperplasia without altering its effects on mammary glands. This evidence concerns the gene ZG16B and breast cancer.